1,3-取代吲唑类低氧诱导因子l抑制剂的设计合成及其抗肝癌活性

doi:10.11944/j.issn.1000-0518.2018.04.170098

摘要/Abstract

摘要：

低氧诱导因子l(HIF-1)与肿瘤细胞的生长、侵袭和耐药密切相关,在肿瘤细胞内HIF-1高度表达,因此新型的HIF-1抑制剂可作为潜在的抗肿瘤药物。本文合成了9个1,3-取代吲唑衍生物。通过蛋白质印迹(Western Blot)法及实时定量荧光PCR(Real time-PCR)等方法检测了其对HIF-1及其靶基因血管内皮生长因子(VEGF)表达水平的影响,并以3-(5'-羟甲基-2'-呋喃基)-1-苯甲基吲唑(YC-1)为阳性对照药物初步评价了其体外抗肝癌细胞增殖的生物活性。实验发现化合物7b可显著抑制HIF-1及其下游靶基因VEGF的表达,且体外抗肝癌增殖生物活性优于YC-1,半抑制浓度(IC₅₀)值为10.37 μmol/L。研究结果表明,3-(5'-羟甲基-2'-呋喃)-1-(1″-对甲苯磺酰基)吲唑具有靶向抑制HIF及良好的抗肝癌活性作用。

关键词: 吲唑, HepG2细胞, 低氧诱导因子l, 抗肝癌活性

Abstract:

Hypoxia-inducible factor 1(HIF-1) is closely related to the growth, invasion and drug resistance of tumor cells and is highly expressed in tumor cells, so new HIF-1 inhibitors can be used as potential antitumor drugs. Nine 1,3-substituted indazole derivatives were synthesized. The expression of HIF-1 and its target gene vascular endothelial growth factor(VEGF) were detected by Western Blot and Real time-PCR(polymerase chain reaction), and the anti-tumor activities of all the newly synthesized compounds were evaluated on the in vitro growth of HepG2 cell line taking 3-(5'-hydroxymethyl-2'-furyl)-1-benzyl indazole(YC-1)(compound 7d) as positive control. We found that compound 7b significantly inhibited the expression of HIF-1 and its downstream target gene VEGF, and the anti-hepatoma biological activity in vitro of compound 7b was better than that of YC-1 with half maximal inhibitory concentration(IC₅₀) values of 10.37 μmol/L. The results show that 3-(5'-hydroxy methyl-2'-furan)-1-(1' -p-tolylsulfonyl) indazole targets the inhibition of HIF activity, but also has a good anti-hepatoma activity.

Key words: indazole, hepG2 cells, hypoxia-inducible factor 1, anti-hepatoma activity

李善花,黄志宁,苗方笑,郑满意,梁涵,王宝睿,曲宁,乔红,王海莉,李福男. 1,3-取代吲唑类低氧诱导因子l抑制剂的设计合成及其抗肝癌活性[J]. 应用化学, 2018, 35(4): 410-419.

LI Shanhua,HUANG Zhining,MIAO Fangxiao,ZHENG Manyi,LIANG Han,WANG Baorui,QU Ning,QIAO Hong,WANG Haili,LI Funan. Synthesis and Anti-Hepatoma Activities of 1,3-Substituted Indazole Derivatives as Hypoxia Induced Factor Inhibitors[J]. Chinese Journal of Applied Chemistry, 2018, 35(4): 410-419.

参考文献

[1]	LIANG Hongyuan,LU Zaiming.Current Situation and Perplexity of Comprehensive Interventional Therapy for Primary Liver Cancer[J]. J Clin Hepatol,2016,32(1):44-48(in Chinese). 梁宏元,卢再鸣. 原发性肝癌综合介入治疗现状与困惑[J]. 临床肝胆病杂志,2016,32(1):44-48.
[2]	Denko N C.Hypoxia, HIF1 and Glucose Metabolism in the Solid Tumour[J]. Nat Rev Cancer,2008,8(9):705-713.
[3]	Tsui L,Fong T H,Wang I J.YC-1 Targeting of Hypoxia-Inducible Factor-1Α Reduces RGC-5 Cell Viability and Inhibits Cell Proliferation[J]. Mol Vis,2012,18:1594-1603.
[4]	Tsui L,Fong T H,Wang I J.The Effect of 3-(5-Hydroxymethyl-2'- Furyl)-1-Benzylindazole(YC-1) on Cell Viability Under Hypoxia[J]. Mol Vis,2013,19:2260-2273.
[5]	Lobb K,Hipskind P,Aikins J,et al. Acyl Sulfonamide anti-Proliferatives:Benzene Substituent Structure-Activity Relationships for a Novel Class of Antitumor Agents[J]. J Med Chem,2004,47(22):5367-5380.
[6]	LIU Fei,LIU Nan,HE Ling.Synthesis and Antitumor Activities of Sulfonyl Amidine Derivatives[J]. Chinese J Synth Chem,2014,22(4):440-443(in Chinese). 刘菲,刘楠,何菱. 磺酰脒衍生物的合成及其抗肿瘤活性[J]. 合成化学,2014,22(4):440-443.
[7]	Yang S M,Huang Z N,Zhou Z S,et al. Structure-based Design, Structure-Activity Relationship Analysis, and Antitumor Activity of Diaryl Ether Derivatives[J]. Arch Pharm Res,2015,38(10):1761-1773.
[8]	Hou J,Zhao W,Huang Z N,et al. Evaluation of Novel N-(Piperidin-4-Yl) Benzamide Derivativesas Potential Cell Cycle Inhibitors in HepG2 Cells[J]. Chem Biol Drug Des,2015,86(2):223-231.
[9]	Xiao J,Jin C,Liu Z,et al. The Design, Synthesis, and Biological Evaluation of Novel YC-1 Derivatives as Potent Anti-Hepatic Fibrosis Agents[J]. Org Biomol Chem,2015,13(26):7257-7264.
[10]	Zhang D,Kohlman D,Krushinski J,et al. Design, Synthesis and Evaluation of Bicyclic Benzamides as Novel 5-HT 1F Receptor Agonists[J]. Bioorg Med Chem Lett,2004,14(24):6011-6016.
[11]	An H,Kim N J,Jung J W,et al. Design, Synthesis and Insight into the Structure Activity Relationship of 1,3-Disubstituted Indazoles as Novel HIF-1 Inhibitors[J]. Bioorg Med Chem Lett,2011,21(21):6297-6300.
[12]	Gamet-Payrastre L,Li P,Lumeau S,et al. Sulforaphane, a Naturally Occurring Isothiocyanate, Induces Cell Cycle Arrest and Apoptosis in HT29 Human Colon Cancer Cells[J]. Cancer Res,2000,60(5):1426-1433.